IRIDEX Corporation Market Share Analysis

GlobalData
November 30, 2011
61 Pages - SKU: GBDT6713158
Offices of Other Holding Companies: State Industry Market Evaluator 551112
12/1/2014 | published by: BizMiner
Offices of Other Holding Companies: State Industry Market Evaluator 551112 This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics  |  read more...
USD 599
Immune Design Corp. - Product Pipeline Review - 2014
12/10/2014 | published by: Global Markets Direct
Immune Design Corp. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
InterMune, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
InterMune, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘InterMune, Inc. - Product Pipeline Review - 2014’, provides an overview of the InterMune, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Italfarmaco S.p.A. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
Italfarmaco S.p.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Italfarmaco S.p.A. - Product Pipeline Review - 2014’, provides an overview of the Italfarmaco S.p.A.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Innocoll Technologies Ltd - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary Innocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets pharmaceutical products and medical devices for the pharmaceutical and medical markets. Its products include cogenzia, xaracoll, gentamicin surgical implant, procoll, and  |  read more...
USD 750
InBios International, Inc. - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary InBios International, Inc. (InBios International) is a medical diagnostic company. The company develops, manufactures and markets medical diagnostic tests for the detection of infectious diseases. It offers immunochemistry test reagents and clinical chemistry test reagents  |  read more...
USD 750
ImmuVen, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
ImmuVen, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘ImmuVen, Inc. - Product Pipeline Review - 2014’, provides an overview of the ImmuVen, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
IBM (IBM: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/10/2014 | published by: Plunkett Research, Ltd.
IBM (IBM: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (IBM, IBM: NYS) compared to its top competitors and compared  |  read more...
USD 1,795
Imation Corp (IMN: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/11/2014 | published by: Plunkett Research, Ltd.
Imation Corp (IMN: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Imation Corp, IMN: NYS) compared to its top competitors  |  read more...
USD 1,795
Emulex Corp (ELX: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/13/2014 | published by: Plunkett Research, Ltd.
Emulex Corp (ELX: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Emulex Corp, ELX: NYS) compared to its top competitors  |  read more...
USD 1,795
 

SELECT A LICENSE

    Online Download  USD 1,000  
    Global Site License  USD 3,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!